News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Micro Cap Biotech Secures $60M to Advance Alzheimer's Treatment, Shares Surge [Globe and Mail, The (Toronto, Canada)]

Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer's Disease [Yahoo! Finance]

Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease

Top News Decliners

2/28 Vaccinex Inc (NASDAQ: VCNX) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -18.3%

11/9 Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) -11.1%

3/17 Vaccinex Inc (NASDAQ: VCNX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -9.9%

3/23 Form 4 VACCINEX, INC. For: Mar 19 Filed by: FRIEDBERG ALBERT -9.4%

4/1 Form 4 VACCINEX, INC. For: Mar 31 Filed by: Frieberg Jacob B. -9.1%

3/26 Form 4 VACCINEX, INC. For: Mar 24 Filed by: FCMI Parent Co. -8.1%

1/27 Form SC 13D/A VACCINEX, INC. Filed by: FCMI Parent Co. -8.1%

10/19 Vaccinex Inc (NASDAQ: VCNX) had its "hold" rating re-affirmed by analysts at Zacks Investment Research. -7.7%

10/2 Form 4 VACCINEX, INC. For: Sep 30 Filed by: VACCINEX, INC. -7.2%

6/5 Vaccinex Inc (NASDAQ: VCNX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -7.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}